Dan Savyckyj
About Dan Savyckyj
Dan Savyckyj is the Director of Corporate and Business Development at Bristol Myers Squibb in New Jersey, with extensive experience in the pharmaceutical industry.
Title at Bristol Myers Squibb
Dan Savyckyj is currently serving as the Director of Corporate and Business Development at Bristol Myers Squibb in New Jersey, United States. In this role, he is involved in managing strategic partnerships and alliances, with a focus on advancing corporate growth within the biopharmaceutical industry.
Previous Experience at GSK
Dan Savyckyj previously held the position of Director at GSK from 2015 to 2021. During his six-year tenure in New Jersey, he contributed to various significant projects and initiatives, furthering the company's objectives in the pharmaceutical sector.
Role at Novartis
Before GSK, Dan served as the Associate Director at Novartis from 2012 to 2015. Over his three years at Novartis, he focused on driving strategic initiatives and corporate development within the company, thereby enhancing its market and operational performance.
Educational Background
Dan Savyckyj has a robust educational background. He earned a Master's in Business Administration from Georgetown University (1995-1997), Post Baccalaureate Pre-Med from the University of Pennsylvania (2003-2005), and a Bachelor's in European History also from the University of Pennsylvania. Further enhancing his qualifications, he studied at Thomas Jefferson University from 2006 to 2009.
Experience in Asset Management
Dan has also worked extensively in asset management. He was the Director and Portfolio Manager at Evergreen Investments from 2000 to 2002, where he managed investment portfolios. Prior to that, he served as an Analyst at Baring Asset Management (1997-2000), where he focused on analyzing market trends and investment opportunities.
Early Career at IFC
Dan Savyckyj began his professional journey as an Analyst at the International Finance Corporation (IFC) from 1992 to 1995. Based in Ukraine, he contributed to various analytical projects, setting a strong foundation for his subsequent roles in the industry.
Work at Celgene
Before joining Bristol Myers Squibb, Dan also worked at Celgene, a leading biopharmaceutical company. His experience at Celgene likely included involvement in biopharmaceutical research and development, adding to his extensive expertise in this field.